TTN-AS1 is overexpressed in cervical cancer, and its upregulation obviously correlates with the International Federation of Gynecology and Obstetrics (FIGO) stage, poor differentiation, and lymph node metastasis [24]. Here, TTN is linked to cervical carcinoma.